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Non-communicable diseases (NCD) have been increasing in 
the world, such as obesity, diabetes and metabolic syndrome [1]. 
Consequently, adequate nutritional treatments would be neces-
sary as the fundamental therapy in each country [2].
There have been several dietary guidelines, which focus on not 
overall macronutrients ratio or total fat, but on the lower amount 
of saturated fat and trans-fat [3,4]. On contrast, decreasing intake 
of total fat less than 30% in energy has been recommended in oth-
er guidelines [5]. 
Historically speaking, Low Carbohydrate Diet (LCD) was 
launched in 1980-1990 by two known investigators in Europe-
an and North American regions [6,7]. After that, LCD has been 
recognized and accepted for many people in comparison of Cal-
orie Restriction (CR). One of the reasons was that the exchange 
carbohydrates with greater intake of protein or fat have gained 
clinical efficacy [8,9]. They include ability of LCD to bring remark-
able weight reduction in short-term [10]. On the other hand, there 
have been conflicting and incomplete results for long-term clini-
cal influence for health outcomes [11,12]. Furthermore, data from 
meta-analyses such as some large cohort studies have suggested 
possible relationship between low carbohydrate intake and ele-
vated mortality rate [13,14]. 
There were two important reports in 2012, where negative 
and positive results were found, respectively. The former showed 
that Low carbohydrate-high protein diets are associated with in-
creased risk of cardiovascular disease [15]. The latter showed that 
isocaloric meal after weight reduction 10-15% have resulted in 
decreases in resting energy expenditure (REE) and total energy 
 
expenditure (TEE), which were the greatest in the low-fat diet, in-
termediate in the low-glycemic index diet, and the least in the very 
low-carbohydrate diet [16].
NIPPON DATA (National Integrated Project for Prospective 
Observation of Non-communicable Disease And its Trends in the 
Aged) analyzed 9200 from 13771 subjects. The results showed 
that moderate diets lower in carbohydrate and higher in protein 
and fat were significantly inversely associated with CVD and total 
mortality in women [17]. 
One of the reliable mega study was the 2017 Prospective Ur-
ban Rural Epidemiology (PURE) study. It included many individu-
als from 18 countries across five continents with 7.4 years follow 
up in median and 5796 deaths from 135,335 subjects. The result 
was that high carbohydrate intake was found with elevated risk 
ratio of mortality [18]. According to the obtained data, the discus-
sion concerning the influence of carbohydrate ratio has continued 
for the possible revision to some standard nutritional guidelines 
[19]. 
Thus, LCD has developed with such situations in Europe and 
the United States. On the other hand, Dr. Ebe has launched LCD 
treatment in Japan, who is our research collaborator [20]. After 
that, we have developed various kinds of clinical practice and re-
search of LCD for years. Among them, research themes include i) 
weight reduction efficacy in thousands of patients, ii) daily profile 
of blood glucose and Morbus (M) value in comparison with CR and 
LCD, iii) hyperketonemia due to continuation of LCD, iv) elevated 
ketone bodies in the axis of fetus, placenta, newborn and mother, 
v) meal tolerance test using CR breakfast with 70g of carbohy-
drate, and so on [21-23]. 
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In primary care setting, the proposal of three kinds of LCD 
meal to the patients would be simple and effective, which are 
super-LCD, standard-LCD and petit-LCD [24]. Using these three 
methods, we have established Japanese LCD Promotion Associa-
tion (JLCDPA) and developed the knowledge and practice of what 
is LCD like to many people in Japan through various activities. 
LCD has become rather popular, and the continuation of LCD 
seems to be clinically beneficial from various points of view. Ac-
cording to Feinman & Bernstein et al. [25] suggested definitions 
for various types of low-carbohydrate diets are as follows: 1) Very 
low-carbohydrate ketogenic diet (VLCKD), 2) Low-carbohydrate 
diet: <130 g/d or <26% total energy, 3) Moderate-Carbohydrate 
Diet: 26%–45%, 4) High-Carbohydrate Diet: >45%. 
Recently, there is a report that has an objection data to previ-
ous clinical efficacy of LCD. The Atherosclerosis Risk in Commu-
nities (ARIC) Study has started and continued for some decades 
[26]. ARIC study included more than 432 thousand subjects with 
25 years [27]. From ARIC cohort study after multivariable adjust-
ment, there was a U-shaped association between the percentage 
of energy of carbohydrate (mean 48·9%, SD 9·4) and mortality. 
By calculating and comparing total carbohydrate ratio, daily meal 
with high (>70%) or low (<40%) percentage of energy from car-
bohydrates were associated with increased mortality, with mini-
mal risk observed between 50–55% [27].
Obtaining the optimal carbohydrate intake amount for the ev-
idence to guidance recommendations, a population-based study 
of overall carbohydrate consumption was performed. In particu-
lar, the association of carbohydrate intake with mortality and re-
sidual lifespan was specifically investigated. When LCD is chosen 
for weight reduction or cardiometabolic risk reduction, replace-
ment of carbohydrates with proteins and plant-based fats would 
be recommended for an adequate approach for healthy life and 
aging [27]. 
However, careful interpretation of this result may be neces-
sary. The reason is from several variables and adjusted data, in-
cluding that i) results differ depending on whether the substitute 
food is animal or vegetable, ii) lowest total mortality rate is not 
consistently found under various conditions, iii) multiple factors 
are adjusted and calculated such as country, disease, diabetes, 
physical activity, smoking, west-hip ratio and so on. 
In summary, this article showed the development and outline 
of LCD. Comparison between CR and LCD, effect of LCD, and ar-
teriosclerotic influence on mega study would be expected to be 
investigated in the future. Further study will bring each patient in 
each country beneficial diet style, better QOL, ADL and happiness.
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